NVRO - NEVRO CORP ()

NVROのニュース

   Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy  2021/01/19 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the results from data presentations at NANS supporting the use of HF10®…
   Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting  2021/01/14 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 14, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HF10®…
   Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue  2021/01/11 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 11, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its preliminary, unaudited revenue for the fourth quarter and full-year…
   Spinal Cord Stimulator Market to Witness Huge Growth by 2027| Key Players are Boston Scientific Corp., Medtronic, St Jude, Nevro Corp, Nuvectra Corporation, Stimwave, Saluda Medical PTY Limited, Cyberonics, NeuroPace and Synapse Biomedical  2021/01/08 14:50:17 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Spinal Cord Stimulator Market Research Report 2021”. The Global Spinal Cord Stimulator Market Report 2021 is a professional and in-depth study on the current state of the
   Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California  2020/12/14 23:54:00 PR Newswire
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO)…
   Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California  2020/12/14 23:54:00 PR Newswire
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO)…
   Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific  2020/12/14 21:30:00 PR Newswire
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic…
   Neurostimulation Devices Market Opportunities 2020 with Industry Size, Growth, Trends and Forecast by 2027 | Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation  2020/12/08 12:34:46 OpenPR
Global Neurostimulation Devices Market Analysis to 2025 is a specialized and in-depth study of the Neurostimulation Devices industry with a focus on the global market trend. The report aims to provide an overview of global Neurostimulation Devices Market with detailed
   Nevro Announces Director Appointment  2020/12/03 12:00:00 PR Newswire
REDWOOD CITY, Calif., Dec. 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that Susan E. Siegel has been appointed as a member of the Board of…
   ­Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th  2020/11/24 12:00:00 PR Newswire
REDWOOD CITY, Calif., Nov. 24, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President will…
   Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California  2020/12/14 23:54:00 PR Newswire
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO)…
   Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific  2020/12/14 21:30:00 PR Newswire
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic…
   Neurostimulation Devices Market Opportunities 2020 with Industry Size, Growth, Trends and Forecast by 2027 | Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation  2020/12/08 12:34:46 OpenPR
Global Neurostimulation Devices Market Analysis to 2025 is a specialized and in-depth study of the Neurostimulation Devices industry with a focus on the global market trend. The report aims to provide an overview of global Neurostimulation Devices Market with detailed
   Nevro Announces Director Appointment  2020/12/03 12:00:00 PR Newswire
REDWOOD CITY, Calif., Dec. 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that Susan E. Siegel has been appointed as a member of the Board of…
   ­Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th  2020/11/24 12:00:00 PR Newswire
REDWOOD CITY, Calif., Nov. 24, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President will…

calendar